Emendo Biotherapeutics vs Kolgene
Emendo Biotherapeutics vs Kolgene, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Kolgene on 15/100.
Where each one leads
Emendo Biotherapeutics
- our overall score: 59/100 against 15/100
- agent readiness: 40/100 against 21/100
- domain rating: 20/100 against 2/100
- headcount: 41 against 2
- LinkedIn following: 5,333 against 317
Kolgene
- headcount growth: +17.2% against -16.1%
At a glance
| Measure | Emendo Biotherapeutics | Kolgene |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | Platform for managing genetic test send-out operations for medical professionals. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Healthcare, Genomics, HealthTech, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2015 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Kolgene |
|---|---|---|
| Employees | 41 | 2 |
| Headcount growthLast 12 months | -16.1% | +17.2% |
| Total funding | $61.0M | Not published |
| Latest round | Series B | Bootstrapped |
| LinkedIn followers | 5,333 | 317 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Kolgene |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 15/100 |
| Traction | 55/100 | 5/100 |
| Team | 40/100 | Not published |
| Search visibility | 44/100 | 22/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 2/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Kolgene |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Emendo Biotherapeutics vs Kolgene: common questions
Which is better, Emendo Biotherapeutics or Kolgene?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Kolgene compare on the numbers?
Emendo Biotherapeutics leads on our overall score (59/100 against 15/100), agent readiness (40/100 against 21/100), domain rating (20/100 against 2/100), headcount (41 against 2), LinkedIn following (5,333 against 317). Kolgene leads on headcount growth (+17.2% against -16.1%).
Read the full Emendo Biotherapeutics review and pricing or the Kolgene review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.